Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DNA sequencing
MedTech
Oxford Nanopore, SeqOne ink rare disease diagnostic partnership
The goal will be to provide an end-to-end platform that applies extra-long nanopore sequencing reads to whole genomes.
Conor Hale
Mar 15, 2024 3:10pm
Patient Square Capital to roll up NanoString assets for $220M
Mar 12, 2024 1:07pm
Protein parser Alamar Bio collects $128M for analyzer launch
Mar 1, 2024 10:58am
Clinical Microbiomics snaps up DNASense
Mar 1, 2024 9:00am
NanoString files for bankruptcy, explores potential sale
Feb 5, 2024 10:24am
JPM24: PacBio puts up 56% annual growth
Jan 11, 2024 11:52am